Vcanbio Cell & Gene Engineering Corp

Vcanbio Cell & Gene Engineering Corp Years Dividend Increased

Years of Consecutive Dividend Increases of Vcanbio Cell & Gene Engineering Corp (600645.SS) as of Nov 16, 2026.

Years Dividend Increased

0

Last updated:

Years of Consecutive Dividend Increases of Vcanbio Cell & Gene Engineering Corp is 2025 0 . Years of Consecutive Dividend Increases of Vcanbio Cell & Gene Engineering Corp was 2024 0.00 . It decreases by % lower compared to the previous year.

The Vcanbio Cell & Gene Engineering Corp Years Dividend Increased history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Years Dividend Increased
Date
Years Dividend Increased
Jan 1, 2018
0.00 CNY
Jan 1, 2019
0.00 CNY
Jan 1, 2020
0.00 CNY
Jan 1, 2021
0.00 CNY
Jan 1, 2022
0.00 CNY
Jan 1, 2023
0.00 CNY
Jan 1, 2024
0.00 CNY
Jan 1, 2025
0.00 CNY
The Vcanbio Cell & Gene Engineering Corp Years Dividend Increased history
YEARYears Dividend IncreasedYoY
0—
0—
0—
0—
0—
0—
0—
0—
0—
0—
0—
0—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Vcanbio Cell & Gene Engineering Corp Stock analysis

What does Vcanbio Cell & Gene Engineering Corp do? Vcanbio Cell & Gene Engineering Corp., Ltd. generates revenue through the development and sale of life sciences technology products. The company produces cytokines culture solutions, cosmetics, and detection reagents for domestic markets. Its business segments include cell culture, gene detection and storage, and the production of specialized biological products. The firm's domestic customers primarily purchase these products for research and commercial applications in the life sciences sector. Vcanbio focuses on cell culture and gene detection services, which are integral to its product offerings. The company's cytokines culture solutions are sold to domestic clients in the biotechnology and pharmaceutical industries. Detection reagents are also marketed to domestic laboratories and healthcare providers for diagnostic purposes. The firm leverages its 2,332 full-time employees to support research, development, and production activities. The company's product portfolio includes cosmetics alongside scientific reagents, targeting both consumer and professional markets. Domestic markets remain the primary focus for all sales, with no mention of international operations. Vcanbio's revenue streams are derived from the sale of its core products, which are developed and manufactured in-house. Vcanbio Cell & Gene Engineering Corp is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Vcanbio Cell & Gene Engineering Corp stock

On Eulerpool you can find the complete historical development of Years of Consecutive Dividend Increases Vcanbio Cell & Gene Engineering Corp since 2006 – with annual values, charts, and detailed analysis.

This measures how many consecutive years the dividend has been raised. Companies with 25+ years are considered Dividend Aristocrats.

Years of Consecutive Dividend Increases's is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Years of Consecutive Dividend Increases's Vcanbio Cell & Gene Engineering Corp historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Dividend — Vcanbio Cell & Gene Engineering Corp

All Key Metrics — Vcanbio Cell & Gene Engineering Corp